Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Positive EU CHMP Opinions for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) in Two Different Types of Cancer
TOKYO and KENILWORTH, N.J., Oct 18, 2021 – (JCN Newswire) – Eisai and Merck &…
Inside a Fake DHL Campaign Built to Steal Credentials
Guardz Report: 9 Out Of 10 SMBs Have Compromised Users as AI-Driven Attacks Reshape the MSP Threat Landscape
Aerospike’s New AI-native Developer Experience Optimized for Rapid, High-quality Coding by Humans and AI Agents